Thoracic Cancer SCIE

國際簡稱：THORAC CANCER 參考譯名：胸腺癌

主要研究方向：ONCOLOGY-RESPIRATORY SYSTEM 非預警期刊審稿周期：約2月

《胸腺癌》(Thoracic Cancer)是一本由Blackwell Publishing Asia Pty Ltd出版的以ONCOLOGY-RESPIRATORY SYSTEM為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應用學科的最新發(fā)現(xiàn)，旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
374 年發(fā)文量
2.3 IF影響因子
開放是否OA
20 H-index
2010 創(chuàng)刊年份
12 issues/year 出版周期
English 出版語言

Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.

The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.

[ 查看全部 ]

投稿咨詢加急咨詢

Thoracic Cancer期刊信息

ISSN：1759-7706
出版語言：English
是否OA：開放
E-ISSN：1759-7714
出版地區(qū)：PEOPLES R CHINA
是否預警：否
出版商：Blackwell Publishing Asia Pty Ltd
出版周期：12 issues/year
創(chuàng)刊時間：2010
開源占比：0.6669
Gold OA文章占比：68.37%
OA被引用占比：1
出版國人文章占比：0.6
出版撤稿占比：0
研究類文章占比：94.65%

Thoracic Cancer CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

5.2

0.778

0.785

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Pulmonary and Respiratory Medicine	Q2	54 / 155	65%
大類：Medicine 小類：Oncology	Q2	160 / 404	60%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Thoracic Cancer中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統(tǒng)	4區(qū) 4區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統(tǒng)	3區(qū) 3區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統(tǒng)	3區(qū) 3區(qū)

中科院 2021年12月基礎版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統(tǒng)	3區(qū) 3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統(tǒng)	3區(qū) 3區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫(yī)學	3區(qū)	ONCOLOGY 腫瘤學 RESPIRATORY SYSTEM 呼吸系統(tǒng)	3區(qū) 3區(qū)

Thoracic Cancer JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：ONCOLOGY	SCIE	Q3	201 / 322	37.7%
學科：RESPIRATORY SYSTEM	SCIE	Q2	50 / 100	50.5%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：ONCOLOGY	SCIE	Q3	177 / 322	45.19%
學科：RESPIRATORY SYSTEM	SCIE	Q2	50 / 101	50.99%

Thoracic Cancer歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Thoracic Cancer中國學者發(fā)文選摘

1、The kinesin light chain-2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC
Author: Qiao, Simiao; Jiang, Yuhang; Li, Na; Zhu, Xiaoxia

Journal: THORACIC CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1111/1759-7714.14886
2、A single-center study of thoracoscopic surgery in the treatment of pediatric mediastinal neurogenic tumors
Author: Zhang, Qiangye; Zhou, Tingting; Hou, Peimin; Mu, Weijing; Wang, Dongming; Fang, Jun; Li, Aiwu

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 1, pp. 44-51. DOI: 10.1111/1759-7714.14708
3、Real-world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2-advanced breast cancer
Author: Hao, Chunfang; Bai, Xuedong; Zhang, Jie; Meng, Wenjing; Tong, Zhongsheng

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 1, pp. 68-72. DOI: 10.1111/1759-7714.14715
4、The T stage of esophageal cancer can be effectively predicted by muscularis propria thickness and muscularis propria plus mucosa thickness under ultrasonic gastroscopy
Author: Yu, Yongkui; Wei, Xiufeng; Chen, Xiankai; Li, Haomiao; Liu, Qi; Sun, Haibo; Wang, Wei; Wang, Lifeng; Li, Yin; Xing, Wenqun

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 2, pp. 127-134. DOI: 10.1111/1759-7714.14722
5、Molecular profiles of single circulating tumor cells from early breast cancer patients with different lymph node statuses
Author: Pang, Shuyun; Xu, Shu; Wang, Lulu; Wu, Haiping; Chu, Yanan; Ma, Xueping; Li, Yujiao; Zou, Bingjie; Wang, Shaohua; Zhou, Guohua

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 2, pp. 156-167. DOI: 10.1111/1759-7714.14728
6、Real-world treatment and prognostic factors for survival in ALK plus non-small cell lung cancer (NSCLC) patients with brain metastases in China
Author: Li, Na; Xie, Mingying; Zhou, Zichao; Sheng, Jiamin; Yu, Xiaoqing; Fan, Yun

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 3, pp. 237-245. DOI: 10.1111/1759-7714.14739
7、Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort
Author: Tian, Wenxin; He, Jing; Yu, Hanbo; Sun, Yaoguang; Wu, Qingjun; Jiao, Peng; Ma, Chao; Huang, Chuan; Li, Donghang; Tong, Hongfeng

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 2, pp. 135-142. DOI: 10.1111/1759-7714.14723
8、Separated precise subsegmentectomy: Single-port thoracoscopic noncombined subsegmentectomy in one lung lobe
Author: Zhang, Shuliang; Chen, Maohui; Huang, Yizhou; Huang, Guanglei; Zeng, Taidui; Zheng, Wei; Chen, Chun; Zheng, Bin

Journal: THORACIC CANCER. 2023; Vol. 14, Issue 3, pp. 274-280. DOI: 10.1111/1759-7714.14746